Back to results
US 7,396,825 B2Granted
Agonists of A2A adenosine receptors for treatment of diabetic nephropathy
AssigneeUniversity of Virginia Patent Foundation
InventorsMark D. Okusa, Joel M. Linden, Timothy L. Macdonald, Alaa S. Awad
Life of this patent
Estimating the term…
Abstract
The present invention provides a therapeutic method for treating diabetic kidney disease, e.g., diabetic nephropathy that includes the administration of an effective amount of an A2A adenosine receptor agonist. Optionally, the method includes administration of a type IV PDE inhibitor.
Claims58
A therapeutic method for treating diabetic nephropathy comprising the administration to a patient in need thereof an effective amount of an A2A adenosine receptor agonist.
Dependencies are inferred from the claim text.